In NOD.Scid recipients, the neutralization of CCL3 with specific antibodies following transfer of diabetogenic T cells delayed the onset of diabetes, while the injection with anti-CCL4 mAb did not [46]. This evidence concerns the gene CCL3 and diabetes mellitus.